Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)

NCT01748812 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Conditions

Osteomalacia

Interventions

DRUG: Osteomalacia

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)